Clonal transmission of a ceftazidime–avibactam-resistant hypervirulent Klebsiella pneumoniae KL64-ST11 strains harboring bla NDM-1 , bla KPC-2 , and ompk36 deletion

Read the full article

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Ceftazidime–avibactam (CZA) exhibits promising activity against carbapenem-resistant Klebsiella pneumoniae (CRKP). However, CZA-resistant CRKP (CRKP CZA−R ) strains have been emerging. This study explored the mechanism underlying CZA resistance in these strains. CRKP CZA−R was screened from non-repetitive CRKP at our hospital from January 1, 2018 to October 30, 2021. The drug resistance mechanism and homology were analyzed through carbapenemase phenotype detection and next-generation sequencing. In total, 67 of 623 isolates (10.8%) were CRKP CZA−R . The most prevalent resistant genes were bla NDM−1 (44.8%, 30/67), followed by bla IMP−4 (9.0%, 6/67), bla NDM−5 (7.5%, 5/67), and bla NDM−4 (1.5%, 1/67). Furthermore, 37.3% (25/67) of CRKP CZA−R simultaneously harbored more than two carbapenemase-encoding genes. The enzyme inhibitor enhancement method detected the carbapenemase with high sensitivity (82.1%), particularly for strains harboring a single carbapenemase (100%). However, the presence of two or more carbapenemase limited its detection ability. Notably, 21 ST11-KL64 CRKP CZA−R exhibiting bla NDM−1 , bla KPC−2 , and also with ompk36 deletion, and 17 co-carried two or more high virulence gene markers, suggesting clonal transmission. Patients infected with these 21 strains were older and more serious than other drug-resistant strains, which were higher with MIC 50 of fosfomycin than other drug-resistant strains. In conclusion, the detection rate of CRKP CZA−R was relatively high, which could be attributed to the transmission of MBL genes. Although enzyme inhibitor enhancement method can detect carbapenemases with high sensitivity and specificity, it might have limited detection ability for strains that simultaneously produce more than two carbapenemases. Patients infected with CRKP CZA−R harboring both bla KPC−2 and bla NDM−1 should be closely monitored.

Article activity feed